07:00 , Mar 19, 2012 |  BC Week In Review  |  Company News

AmberGen, Werfen deal

Werfen's Inova Diagnostics Inc. subsidiary received rights to two autoantigen biomarkers for primary biliary cirrhosis (PBC) from AmberGen and the Massachusetts General Hospital . Inova will add the biomarkers to its FDA-approved PBC tests. Terms...
08:00 , Jan 20, 2003 |  BC Week In Review  |  Company News

AmberGen other research news

Researchers published in Nature Biotechnology the use of HTS-PTT to screen for truncated APC proteins, which frequently result from mutations in the APC gene . The test uses an ELISA format amenable to use in...
08:00 , Jan 20, 2003 |  BioCentury  |  Tools & Techniques

Avoiding colonoscopy

SNP detection can be used to diagnose cancers and other diseases, but it is impractical in situations where mutations are numerous and distributed throughout the gene rather than confined to a single region. Other techniques...
08:00 , Oct 29, 2001 |  BioCentury  |  Finance

Ebb & Flow

Big drug makers may be among the favorite whipping boys of both politicians and consumers these days, but their biotech siblings have been a favorite of investors since Sept 11. Last week's 8% gain in...